HCM
DGX icon

Hilton Capital Management’s Quest Diagnostics DGX Stock Holding History

Hilton Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.5M Buy
49,758
+547
+1% +$107K 0.72% 32
2026
Q1 		$9.64M Buy
49,211
+1,435
+3% +$279K 0.73% 33
2025
Q4 		$8.29M Buy
47,776
+438
+0.9% +$79.8K 0.62% 37
2025
Q3 		$9.02M Sell
47,338
-3,378
-7% -$599K 0.73% 34
2025
Q2 		$9.11M Sell
50,716
-343
-0.7% -$59.6K 0.73% 36
2025
Q1 		$8.64M Buy
51,059
+821
+2% +$135K 0.73% 36
2024
Q4 		$7.58M Sell
50,238
-6,715
-12% -$1.04M 0.66% 46
2024
Q3 		$8.84M Buy
+56,953
New +$8.51M 0.69% 43

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Hilton Capital Management's DGX Position: Q2 2026 in Review

Hilton Capital Management increased its Quest Diagnostics (DGX) stake by 1.1% in Q2 2026, buying an estimated $107K and bringing the position to 49,758 shares worth $10.5M. The position accounts for 0.72% of the portfolio, ranked #32.

Hilton Capital Management first reported a position in DGX in Q3 2024 and has held it in 8 quarters since. 1,109 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Hilton Capital Management held 49,758 shares of Quest Diagnostics worth $10.5M as of Q2 2026.
  • Hilton Capital Management bought 547 Quest Diagnostics shares in Q2 2026, an estimated $107K.
  • Quest Diagnostics made up 0.72% of Hilton Capital Management's portfolio in Q2 2026, its #32 holding.
  • Hilton Capital Management first reported a position in Quest Diagnostics in Q3 2024 and has held it in 8 quarters since.
  • 1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Hilton Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.